Bacil Pharma Ltd

BSE: 524516
Bacil Pharma Ltd - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L24200MH1987PLC043427 Incorporated 08 May 1987 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - BSE: 524516 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹0
Exchange filings
Computed EBITDA · FY 2026
₹99.02 Lakh
▲ 142.52% YoY
Net profit · FY 2026
₹1.56 Cr
▲ 284.83% YoY
Authorised capital
₹20 Cr
Registered with MCA
Paid-up capital
₹14.35 Cr
Issued & subscribed
Open charges
None
Secured borrowings
Company age
39 yrs
Est. 1987
Last financials
Mar 2025
Balance sheet date

About Bacil Pharma Ltd

Data last updated: 14 July 2026

Bacil Pharma Ltd is a public limited company based in Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 08 May 1987, the company has been in operation for over 39 years.

Registered with ROC Mumbai under CIN L24200MH1987PLC043427. Listed on BSE: 524516.

Capital: an authorised share capital of ₹20 Cr and a paid-up capital of ₹14.35 Cr. It is led by directors including Chaitali Kalpataru Shah and Omprakash Pyarelal Sonar.

Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.

The net worth stands at ₹24.81 Cr (down 2.43% YoY). Total assets are valued at ₹27.39 Cr (up 7% YoY).

The company is associated with 1 brand - Bacil Pharma.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bacilpharma.com.

Company Details of Bacil Pharma Ltd
CIN L24200MH1987PLC043427
Registration Number 043427
Incorporation Date 08 May 1987
ROC Mumbai
Listing Status Listed (BSE: 524516)
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Chaitali Kalpataru Shah Additional Director Omprakash Pyarelal Sonar Additional Director Vivek Mukesh Yadav Additional Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    bacilpharma.com
  • Social Media
    Locked
  • Registered Address
    Office G2/G3 Samarpan Complex Next To Mirador Hotel, Link Road Opp Satam Wadi Chakala Sahar Andheri (East), Mumbai, Maharashtra, India – 400099
  • Industry
    Pharma, Drug Formulation & Development
Company report
Bacil Pharma Ltd - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Bacil Pharma Ltd report

Financials, compliance, directors, charges, ownership and filings for Bacil Pharma Ltd in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Bacil Pharma Ltd

Bacil Pharma Ltd operates one associated brand: Bacil Pharma. These brands represent Bacil Pharma Ltd's diversified market presence and brand portfolio.

Brand Description Website
Bacil Pharma
Manufacturer of drugs bacilpharma.com

Auditor Details of Bacil Pharma Ltd

Bacil Pharma Ltd is audited by Sarang Shivajirao Chavan And Associates (ICAI peer reviewed, certificate valid till 2028-06-30) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
Sarang Shivajirao Chavan And Associates (ICAI peer reviewed, certificate valid till 2028-06-30) FY 2026 Declaration of unmodified opinion

Board of Directors of Bacil Pharma Ltd

Bacil Pharma Ltd is currently managed by 3 directors, with 17 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Chaitali Kalpataru Shah Additional Director 16 Jul 2025 1 Years 1 Months Current
Omprakash Pyarelal Sonar
Also directs: Goodspark Trading Private Limited
Additional Director 30 Jun 2026 0 Years 1 Months Current
Vivek Mukesh Yadav
Also directs: Briya Enterprise Limited
Additional Director 30 Jun 2026 0 Years 1 Months Current
View all directors

Financials of Bacil Pharma Ltd FY 2026 filings available

Bacil Pharma Ltd reported revenue of ₹- for FY 2026.

Revenue · FY 2026
₹0
Profit · FY 2026
₹1.56 Cr ▲ 284.83%
Computed EBITDA · FY 2026
₹99.02 Lakh ▲ 142.52%
Revenue₹ Cr · Standalone00.51FY 2019: ₹0 Cr0FY 2019FY 2020: ₹0 Cr0FY 2020FY 2021: ₹0 Cr0FY 2021FY 2022: ₹0 Cr0FY 2022FY 2023: ₹0 Cr0FY 2023FY 2024: ₹0 Cr0FY 2024FY 2025: ₹0 Cr0FY 2025FY 2026: ₹0 Cr0FY 2026
Net Profit₹ Cr · Standalone-4-202FY 2019: ₹0 Cr (loss)-0.3FY 2019FY 2020: ₹0 Cr (loss) · +7.7% YoY-0.3FY 2020FY 2021: ₹0 Cr (loss) · +24.3% YoY-0.2FY 2021FY 2022: ₹4 Cr (loss) · -1513% YoY-3.9FY 2022FY 2023: ₹0 Cr (loss) · +97.4% YoY-0.1FY 2023FY 2024: ₹0 Cr (loss) · +42% YoY-0.1FY 2024FY 2025: ₹0 Cr · +783.9% YoY0.4+783.9%FY 2025FY 2026: ₹2 Cr · +284.8% YoY1.6+284.8%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year00.51Q1'25: ₹0 Cr0Q1'25Q2'25: ₹0 Cr0Q2'25Q3'25: ₹0 Cr0Q3'25Q4'25: ₹0 Cr0Q4'25Q1'26: ₹0 Cr0Q1'26Q2'26: ₹0 Cr0Q2'26Q3'26: ₹0 Cr0Q3'26Q4'26: ₹0 Cr0Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Other Income ₹1.24 Cr ₹66.14 Lakh ₹13.05 Lakh ₹11.46 Lakh ₹5.76 Lakh ₹7.39 Lakh ₹14.28 Lakh ₹9.41 Lakh
Total Income ₹1.24 Cr ₹66.14 Lakh ₹13.05 Lakh ₹11.46 Lakh ₹5.76 Lakh ₹7.39 Lakh ₹14.28 Lakh ₹9.41 Lakh
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹4.89 Lakh ₹13.84 Lakh ₹9.89 Lakh ₹8.62 Lakh ₹6 Lakh ₹5.22 Lakh ₹9.37 Lakh ₹7.87 Lakh
Finance Costs ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Depreciation & Amortisation ₹0 ₹7,000 ₹20,000 ₹27,000 ₹37,000 ₹49,000 ₹82,000 ₹91,000
Other Expenses ₹19.61 Lakh ₹11.47 Lakh ₹8.86 Lakh ₹12.76 Lakh ₹3.85 Cr ₹25.65 Lakh ₹35.65 Lakh ₹34.97 Lakh
Total Expenses ₹24.5 Lakh ₹25.38 Lakh ₹18.95 Lakh ₹21.65 Lakh ₹3.92 Cr ₹31.36 Lakh ₹45.84 Lakh ₹43.75 Lakh
Profit Before Exceptional Items & Tax ₹99.02 Lakh ₹40.76 Lakh -₹5.9 Lakh -₹10.19 Lakh -₹3.86 Cr -₹23.97 Lakh -₹31.56 Lakh -₹34.34 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹99.02 Lakh ₹40.76 Lakh -₹5.9 Lakh -₹10.19 Lakh -₹3.86 Cr -₹23.97 Lakh -₹31.56 Lakh -₹34.34 Lakh
Total Tax Expense -₹56.53 Lakh ₹34,000 ₹1,000 ₹0 -₹2,000 -₹4,000 ₹4,000 -₹11,000
Net Profit ₹1.56 Cr ₹40.42 Lakh -₹5.91 Lakh -₹10.19 Lakh -₹3.86 Cr -₹23.93 Lakh -₹31.6 Lakh -₹34.23 Lakh
Other Comprehensive Income -₹2.17 Cr -₹36,000 ₹17.29 Lakh -₹2.31 Lakh ₹3.69 Cr ₹24.39 Lakh -₹20.89 Lakh ₹1.66 Lakh
Total Comprehensive Income -₹61.88 Lakh ₹40.06 Lakh ₹11.38 Lakh -₹12.5 Lakh -₹16.69 Lakh ₹46,000 -₹52.49 Lakh -₹32.57 Lakh
EBITDA (computed) ₹99.02 Lakh ₹40.83 Lakh -₹5.7 Lakh -₹9.92 Lakh -₹3.86 Cr -₹23.48 Lakh -₹30.74 Lakh -₹33.43 Lakh
Basic EPS ₹1.11 ₹0.64 ₹-0.10 ₹-0.17 ₹-6.55 ₹-0.41 ₹-0.54 ₹-0.58
Diluted EPS ₹1.11 ₹0.64 ₹-0.10 ₹-0.17 ₹-6.55 ₹-0.41 ₹-0.54 ₹-0.58
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹27.39 Cr ₹25.6 Cr ₹1.33 Cr ₹1.13 Cr ₹1.27 Cr ₹4.09 Cr ₹4.11 Cr ₹4.55 Cr
Non-current Assets ₹25.64 Cr ₹22.69 Cr ₹1.27 Cr ₹72.41 Lakh ₹76.99 Lakh ₹3.79 Cr ₹3.82 Cr ₹1.49 Cr
Current Assets ₹1.75 Cr ₹2.91 Cr ₹5.21 Lakh ₹40.33 Lakh ₹50.16 Lakh ₹30.23 Lakh ₹28.59 Lakh ₹55.9 Lakh
Property, Plant & Equipment ₹0 ₹0 ₹62,000 ₹82,000 ₹1.09 Lakh ₹2.51 Cr ₹2.52 Cr ₹2.78 Lakh
Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Trade Receivables ₹1.18 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Cash & Equivalents ₹56.82 Lakh ₹2.86 Cr ₹4.15 Lakh ₹2.88 Lakh ₹22.97 Lakh ₹9.92 Lakh ₹4.26 Lakh ₹6.47 Lakh
Equity (Net Worth) ₹24.81 Cr ₹25.43 Cr ₹1.21 Cr ₹1.1 Cr ₹1.22 Cr ₹1.39 Cr ₹1.39 Cr ₹1.91 Cr
Equity Share Capital ₹13.97 Cr ₹13.97 Cr ₹6.53 Cr ₹6.53 Cr ₹6.53 Cr ₹6.53 Cr ₹6.53 Cr ₹6.53 Cr
Borrowings (Non-current) ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Borrowings (Current) ₹0 ₹16.39 Lakh ₹9.84 Lakh ₹2.06 Lakh ₹3.31 Lakh ₹17.56 Lakh ₹16.88 Lakh ₹9.5 Lakh
Total Debt (computed) ₹0 ₹16.39 Lakh ₹9.84 Lakh ₹2.06 Lakh ₹3.31 Lakh ₹17.56 Lakh ₹16.88 Lakh ₹9.5 Lakh
Current Liabilities ₹2.58 Cr ₹16.48 Lakh ₹11.29 Lakh ₹2.79 Lakh ₹4.71 Lakh ₹2.7 Cr ₹2.72 Cr ₹2.64 Cr
Total Liabilities ₹2.58 Cr ₹16.88 Lakh ₹11.29 Lakh ₹2.79 Lakh ₹4.71 Lakh ₹2.7 Cr ₹2.72 Cr ₹2.64 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹1.66 Cr ₹40.08 Lakh -₹29,000 -₹14.75 Lakh -₹4.01 Cr
Investing Cash Flow -₹3.38 Cr ₹33.67 Lakh ₹7.84 Lakh -₹11.63 Lakh ₹3.81 Cr
Financing Cash Flow -₹61.88 Lakh ₹2.08 Cr -₹6.28 Lakh ₹6.28 Lakh ₹32.75 Lakh
Capital Expenditure ₹0 ₹0 ₹0 ₹0 ₹0
Free Cash Flow (computed) ₹1.66 Cr ₹40.08 Lakh -₹29,000 -₹14.75 Lakh -₹4.01 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹2.34 Cr ₹2.82 Cr ₹1.27 Lakh -₹20.1 Lakh ₹13.07 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Other Income ₹11.34 Lakh ₹6.45 Lakh ₹5.49 Lakh ₹1 Cr ₹8.77 Lakh ₹25,000 ₹56.04 Lakh ₹1.08 Lakh
Total Income ₹11.34 Lakh ₹6.45 Lakh ₹5.49 Lakh ₹1 Cr ₹8.77 Lakh ₹25,000 ₹56.04 Lakh ₹1.08 Lakh
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹0 ₹60,000 ₹63,000 ₹2.95 Lakh ₹3.71 Lakh ₹3.82 Lakh ₹3.91 Lakh ₹2.4 Lakh
Finance Costs ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Depreciation & Amortisation ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹4,000 ₹4,000
Other Expenses ₹7.45 Lakh ₹1.93 Lakh ₹3.02 Lakh ₹7.94 Lakh ₹3.51 Lakh ₹2.58 Lakh ₹3.35 Lakh ₹2.04 Lakh
Total Expenses ₹7.45 Lakh ₹2.53 Lakh ₹3.65 Lakh ₹10.89 Lakh ₹7.22 Lakh ₹6.4 Lakh ₹7.3 Lakh ₹4.48 Lakh
Profit Before Exceptional Items & Tax ₹3.89 Lakh ₹3.92 Lakh ₹1.84 Lakh ₹89.36 Lakh ₹1.55 Lakh -₹6.15 Lakh ₹48.74 Lakh -₹3.4 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹3.89 Lakh ₹3.92 Lakh ₹1.84 Lakh ₹89.36 Lakh ₹1.55 Lakh -₹6.15 Lakh ₹48.74 Lakh -₹3.4 Lakh
Total Tax Expense -₹58.27 Lakh ₹0 ₹46,000 ₹22.49 Lakh ₹0 ₹0 ₹34,000 ₹0
Net Profit ₹62.16 Lakh ₹3.92 Lakh ₹1.38 Lakh ₹66.87 Lakh ₹1.55 Lakh -₹6.15 Lakh ₹48.4 Lakh -₹3.4 Lakh
Other Comprehensive Income -₹2.26 Cr ₹2.18 Lakh -₹46,000 ₹6.33 Lakh -₹4.32 Lakh ₹1.35 Lakh -₹22.04 Lakh ₹24.64 Lakh
Total Comprehensive Income -₹1.64 Cr ₹6.1 Lakh ₹92,000 ₹73.2 Lakh -₹2.77 Lakh -₹4.8 Lakh ₹26.36 Lakh ₹21.24 Lakh
EBITDA (computed) ₹3.89 Lakh ₹3.92 Lakh ₹1.84 Lakh ₹89.36 Lakh ₹1.55 Lakh -₹6.15 Lakh ₹48.78 Lakh -₹3.36 Lakh
Basic EPS ₹0.44 ₹0.03 ₹0.01 ₹0.48 ₹0.20 ₹-0.10 ₹0.82 ₹0.06
Diluted EPS ₹0.44 ₹0.03 ₹0.01 ₹0.48 ₹0.20 ₹-0.10 ₹0.82 ₹0.06
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Bacil Pharma Ltd. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Bacil Pharma Ltd

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 0.00%, retail and other public shareholders hold 100.00% of Bacil Pharma Ltd. The company had 7,226 shareholders on record.

Retail & Others: 100.00%
Mar 2026
QUARTER
100.00% Retail & Others
Promoter holding - history
Now 0.00% · Mar 2026High 42.67% · Jun 2023Low 0.00% · Mar 2026
0%11%22%33%44%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 42.67%Sep 2023: 42.67%Dec 2023: 42.67%Mar 2024: 42.67%Jun 2024: 42.67%Sep 2024: 20.70%Dec 2024: 10.60%Mar 2025: 0.20%Jun 2025: 0.20%Sep 2025: 0.08%Dec 2025: 0.08%Mar 2026: 0.00%42.67%0.00%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters0.00%0.08%0.08%0.20%0.20%10.60%
Public100.00%99.92%99.92%99.80%99.80%89.40%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters0.00%0.20%42.67%
Public100.00%99.80%57.33%
Promoter change (YoY, %pts)-0.20-42.47-

Charges & Borrowings Bacil Pharma Ltd

Bacil Pharma Ltd does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Bacil Pharma Ltd

View historical data on people associated with Bacil Pharma Ltd, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Bacil Pharma Ltd

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Bacil Pharma Ltd

Premium access

GST registrations and filing compliance for Bacil Pharma Ltd

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Bacil Pharma Ltd

Premium access

Credit ratings, litigation, and regulatory alerts for Bacil Pharma Ltd

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Bacil Pharma Ltd

Premium access

MSME payment history for Bacil Pharma Ltd

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Bacil Pharma Ltd

Premium access

Corporate group structure for Bacil Pharma Ltd

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Bacil Pharma Ltd

Premium access

MCA filings and documents for Bacil Pharma Ltd

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Bacil Pharma Ltd

Directors
03 Jul 2026
Dikshant Singh Panwar was appointed as a Company Secretary on 03 Jul 2026 & has been associated with this company since 1 month 17 days.
Directors
30 Jun 2026
Omprakash Pyarelal Sonar was appointed as a Additional Director on 30 Jun 2026 & has been associated with this company since 1 month 20 days.
Directors
30 Jun 2026
Vivek Mukesh Yadav was appointed as a Additional Director on 30 Jun 2026 & has been associated with this company since 1 month 20 days.
Activity
29 Sep 2025
Bacil Pharma Ltd last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Directors
12 Aug 2025
Chaitali Kalpataru Shah was appointed as a Cfo on 12 Aug 2025 & has been associated with this company since 1 year 8 days.
Directors
16 Jul 2025
Chaitali Kalpataru Shah was appointed as a Additional Director on 16 Jul 2025 & has been associated with this company since 1 year 1 month.

Frequently Asked Questions about Bacil Pharma Ltd

Bacil Pharma Ltd is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 08 May 1987 (39+ years old) and is registered under CIN L24200MH1987PLC043427. Listed on BSE: 524516.

The current directors of Bacil Pharma Ltd are:

The primary industry of Bacil Pharma Ltd is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Bacil Pharma Ltd is listed on BSE with code 524516.

Bacil Pharma Ltd can be reached at the registered office: Office G2G3 Samarpan Complex Next To Mirador Hotel, Link Road Opp Satam Wadi Chakala Sahar Andheri East, Mumbai, Maharashtra, India – 400099, or through the website bacilpharma.com.

The authorised capital is ₹20 Cr, and the paid-up capital is ₹14.35 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available